The new fast-tracking system announced to help accelerate uptake of innovative new treatments in the UK, could be held back …
Ministers have sidestepped NICE in their bid to boost innovation in life sciences, and said certain medicines can made available …
A new 'Blueprint' to put innovation at the heart of the NHS and help support the UK life sciences sector …
By Nicola O’BrienRoche is yet to explain its controversial exit from the ABPI, but the company seems determined to make …
Roche is to give up its ABPI membership in a surprise move that could undermine the UK’s system of industry …
People from across the industry are being asked to volunteer as 'ambassadors' for the pharma sector to conduct a large-scale …
The ABPI has unveiled a new proactive agenda which it hopes will help improve the industry’s reputation and relationships with …
The UK government budget delivered in the gloom of the recession has provided good news for the industry, according to …
An underlying principle for joint working between the NHS and the pharmaceutical industry is that it brings benefits to patients. …
Roche and Bayer Schering Pharma have been publically reprimanded for bringing discredit upon the UK pharma industry.Bayer fell foul of …
Pharma must re-invent itself and inject new ideas into its business model by hiring talented people from outside the sector, …
Health Secretary Alan Johnson has been appointed the chair of the Ministerial Industry Strategy Group (MISG) and business secretary Lord …
All gifts from pharma companies to doctors and to medical students – should be banned, according to a new report …
The UK pharmaceutical industry stands to lose £225 million in annual profits under its new pricing agreement with the government. …